about
Ceramide: a common pathway for atherosclerosis?Involvement of calcium-sensing receptor in oxLDL-induced MMP-2 production in vascular smooth muscle cells via PI3K/Akt pathwayAngiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.Investigating Prevalence and Pattern of Long-term Cardiovascular Disorders in Sulphur Mustard-exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients' Feedback on Therapy.Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans.Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular diseaseClinical study of the hypothesis of endogenous collateral wind on acute coronary syndrome: a review.Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities.Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway.Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.Vascular remodeling and prothrombotic markers in subjects affected by familial combined hyperlipidemia and/or metabolic syndrome in primary prevention for cardiovascular disease.Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.
P2860
Q24630011-6DFAE784-F6AE-4FD0-A955-2AAF86F0CCB5Q28581841-0561AF5E-81D0-4603-8E8B-E4B286B5B056Q29347157-CBA283DC-AF6F-4F4A-9F4F-B92E3D149F0EQ30245541-658E494E-9680-473F-90D7-C3FCC8AE5C1BQ33685670-91E286B0-7A04-4305-A598-44A3159B77D0Q36009930-7210FC1D-0D4D-4F71-936E-ADCA940CA24AQ36477722-3EB5E103-BBB0-4A8F-9748-F7F9B5BCF5E5Q38198008-10BA8366-19CA-4FA4-B126-7CA167B79911Q40524187-83C10F78-A7DB-48B0-8AEB-17D621BD0EE9Q42027274-3BAECFC6-DA33-4FA9-A96E-02E55635A4A4Q44735775-9F758A59-D59A-4B55-87D2-0FFEF65622DCQ47223491-DA7826C1-1869-4714-AEE1-F5F4C4C82269Q50916304-A08FFAC5-0B26-4008-B60C-39F714B84C7BQ51461924-EEB453E1-6265-4350-9776-5E0D4D67E4A8Q51475687-E751D497-6498-49BD-B6CB-0F9E7AE4682E
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Matrix metalloproteinases and coronary artery diseases.
@ast
Matrix metalloproteinases and coronary artery diseases.
@en
type
label
Matrix metalloproteinases and coronary artery diseases.
@ast
Matrix metalloproteinases and coronary artery diseases.
@en
prefLabel
Matrix metalloproteinases and coronary artery diseases.
@ast
Matrix metalloproteinases and coronary artery diseases.
@en
P2860
P356
P1433
P1476
Matrix metalloproteinases and coronary artery diseases.
@en
P2093
Kazuyuki Shimada
Uichi Ikeda
P2860
P356
10.1002/CLC.4960260203
P577
2003-02-01T00:00:00Z